SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 41 filers reported holding SAB BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $69,720 | +88.6% | 84,000 | 0.0% | 0.00% | +100.0% |
| Q1 2023 | $36,960 | -25.4% | 84,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $49,552 | -16.0% | 84,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $59,000 | -51.6% | 84,000 | 0.0% | 0.00% | -33.3% |
| Q2 2022 | $122,000 | – | 84,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 78,115 | $294,000 | 0.05% |
| Shaolin Capital Management LLC | 275,000 | $1,034,000 | 0.03% |
| Spectrum Management Group, LLC | 5,030 | $19,000 | 0.00% |
| Veritable, L.P. | 43,551 | $164,000 | 0.00% |
| ALPS ADVISORS INC | 45,083 | $170,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 13,187 | $34,000 | 0.00% |
| Qube Research & Technologies Ltd | 24,179 | $91,000 | 0.00% |
| NORTHERN TRUST CORP | 44,476 | $167,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 301,110 | $1,132,000 | 0.00% |